Ardelyx, Inc. - Common Stock (NQ:ARDX)

Ardelyx delivered a strong quarter thanks to solid demand for its first FDA-approved product. Here's what investors need to know.

Why Ardelyx Stock Soared Today ↗

October 31, 2023

Via The Motley Fool

Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday ↗

October 31, 2023

U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Shares of Ardelyx Were Down Wednesday ↗

October 11, 2023

The company's hopes for approval of a drug to treat chronic kidney disease took a hit.

Via The Motley Fool

Analyst Expectations for Ardelyx's Future ↗

September 12, 2023

Via Benzinga

Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue Guidance

October 31, 2023

Ardelyx, Inc. Reports Employment Inducement Grants

October 30, 2023

These three penny stocks are the ones to buy and hold through the market conditions and the years to come for returns.

3 Penny Stocks to Buy and Hold for the Next 10 Years ↗

October 29, 2023

Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023

October 23, 2023

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

Tesla, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

October 19, 2023

Via Benzinga

Why Ardelyx Stock Popped Today ↗

October 18, 2023

Ardelyx finally received the long-awaited FDA approval for its chronic kidney disease drug.

Via The Motley Fool

Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023

October 18, 2023

Conference call scheduled for 8:00 a.m. Eastern Time

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling more than 1% on Wednesday. The Dow traded down 0.70% to 33,760.26 while the NASDAQ fell 1.45% to 13,338.71. The S&P 500 also...

Crude Oil Rises Sharply; Ardelyx Shares Spike Higher ↗

October 18, 2023

Via Benzinga

Topics Stocks

Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 18, 2023

Gainers Shift Technologies, Inc. (NASDAQ: SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection.

Via Benzinga

Topics Bankruptcy

Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday ↗

October 18, 2023

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Ardelyx Inc. (NASDAQ: ARDX) is One of Wednesday Morning’s Most Active Stocks

October 18, 2023

Via Investor Brand Network

Workhorse (WKHS) Stock Jumps on Drone Business Success ↗

October 18, 2023

Workhorse stock is getting a boost on Wednesday morning after providing WKHS investors with an update on its drone business.

ARDX stock is rallying after the U.S. Food and Drug Administration (FDA) approved Ardelyx's kidney disease treatment.

FDA Sends ARDX Stock Soaring After Approving Ardelyx’s Kidney Disease Drug ↗

October 18, 2023

The FDA approved Ardelyx Inc's (NASDAQ: ARDX) Xphozah (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on...

After Initial Rejection, FDA Approves Ardelyx's Kidney Disease-Related Drug ↗

October 18, 2023

Via Benzinga

Ardelyx Announces Amendment of Debt Financing Agreement with SLR Capital Partners to Provide $50 Million of Additional Committed Capital

October 17, 2023

Additional non-dilutive capital extends runway to support the launch of XPHOZAH® (tenapanor) and continued commercial investment into IBSRELA® (tenapanor) in the U.S.

FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor

October 17, 2023

It's time for another dive into the biggest pre-market stock movers as we list out the top stocks worth watching on Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

October 17, 2023

Ardelyx to Present Data Updates for XPHOZAH (tenapanor) for Hyperphosphatemia at Kidney Week 2023 November 1-5 in Philadelphia, PA

October 13, 2023

Ardelyx Shares Preliminary Data on Use of IBSRELA® (tenapanor) in Pediatric IBS-C Patients at NASPGHAN 2023

10 Health Care Stocks Whale Activity In Today's Session ↗

October 11, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 09, 2023

Via Benzinga

October 04, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Caterpillar Inc. (NYSE: CAT).

Jim Cramer Likes This Oil Giant Up Almost 28% In A Year — 'It Has Room To Grow' ↗

October 02, 2023

Via Benzinga

Ardelyx Announces Publication of Positive Results from T3MPO-3 Long-Term Open-Label Safety Trial of Tenapanor for IBS-C in the Journal of Neurogastroenterology and Motility

September 28, 2023

Tenapanor for Hyperphosphatemia Approved in Japan

September 25, 2023

When all the focus lies on the largest names of the economy, these best penny stocks to buy offer a great risk/reward ratio.

The 3 Best Penny Stocks to Buy Now: September 2023 ↗

September 12, 2023